Light speed measurements

Article

Breaking news from the floor of ESCRS

Best IOL prediction results through connectivity; this was the philosophy behind the new software released for Haag-Streit's LENSTAR LS 900 optical biometer for the entire eye. Presented at the company's booth at ESCRS in Paris, the software is reported to auto-populate biometric parameters, including lens thickness, anatomical ACD (anterior chamber depth) and corneal thickness to the latest IOL calculation tools such as Holladay IOL Consultant, Professor Olsen’s PhacoOptics or Professor Preussner's Okulix. According to the company it also allows easy integration to almost every EMR (electronic medical record) system on the market.

The biometer also functions as a keratometer, pachymeter, pupillometer and IOL calculator, performing up to nine measurements in one shot, including lens thickness. Laser optical technology means users only have to align once before receiving the results.

As well as the software, Haag Streit has been showcasing its completed range of LED powered slit lamps, thanks to the addition of the new BM 900 and BP 900 models. According to the company, last year's introduction of the BQ 900 LED has been recognised as a major step forward in slit lamp biomicroscopy, and the range now provides a sharper slit and improved fluorescein observation.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.